Analystreport

Calithera Biosciences (NASDAQ: CALA) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Calithera Biosciences, Inc.  (CALA) 
Last calithera biosciences, inc. earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: calithera.com